173 related articles for article (PubMed ID: 27628691)
21. A visible wavelength spectrophotometric assay suitable for high-throughput screening of 3-hydroxy-3-methylglutaryl-CoA synthase.
Andrew Skaff D; Miziorko HM
Anal Biochem; 2010 Jan; 396(1):96-102. PubMed ID: 19706283
[TBL] [Abstract][Full Text] [Related]
22. Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity.
Krueger AB; Dehdashti SJ; Southall N; Marugan JJ; Ferrer M; Li X; Ford HL; Zheng W; Zhao R
J Biomol Screen; 2013 Jan; 18(1):85-96. PubMed ID: 22820394
[TBL] [Abstract][Full Text] [Related]
23. High-Throughput Screening for the Discovery of Enzyme Inhibitors.
Lloyd MD
J Med Chem; 2020 Oct; 63(19):10742-10772. PubMed ID: 32432874
[TBL] [Abstract][Full Text] [Related]
24. The nonconserved N-terminus of protein phosphatases 1 influences its active site.
Xie X; Huang W; Xue C; Wei Q
BMB Rep; 2008 Dec; 41(12):881-5. PubMed ID: 19123980
[TBL] [Abstract][Full Text] [Related]
25. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of novel tissue-nonspecific alkaline phosphatase inhibitors with diverse modes of action.
Sergienko E; Su Y; Chan X; Brown B; Hurder A; Narisawa S; Millán JL
J Biomol Screen; 2009 Aug; 14(7):824-37. PubMed ID: 19556612
[TBL] [Abstract][Full Text] [Related]
27. A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitors.
Du Y; Fu RW; Lou B; Zhao J; Qui M; Khuri FR; Fu H
Assay Drug Dev Technol; 2013 Jul; 11(6):367-81. PubMed ID: 23906346
[TBL] [Abstract][Full Text] [Related]
28. Optimization of High-Throughput Methyltransferase Assays for the Discovery of Small Molecule Inhibitors.
Dong G; Yasgar A; Peterson DL; Zakharov A; Talley D; Cheng KC; Jadhav A; Simeonov A; Huang R
ACS Comb Sci; 2020 Aug; 22(8):422-432. PubMed ID: 32525297
[TBL] [Abstract][Full Text] [Related]
29. Interactions between a minimal protein serine/threonine phosphatase and its phosphopeptide substrate sequence.
Ansai T; Dupuy LC; Barik S
J Biol Chem; 1996 Oct; 271(40):24401-7. PubMed ID: 8798696
[TBL] [Abstract][Full Text] [Related]
30. Fluorescent peptide probes for high-throughput measurement of protein phosphatases.
Noble JE; Ganju P; Cass AE
Anal Chem; 2003 May; 75(9):2042-7. PubMed ID: 12720338
[TBL] [Abstract][Full Text] [Related]
31. Exploring Allosteric Inhibitors of Protein Tyrosine Phosphatases Through High-Throughput Screening.
Hayashi T; Hatakeyama M
Methods Mol Biol; 2023; 2691():235-245. PubMed ID: 37355550
[TBL] [Abstract][Full Text] [Related]
32. AlphaScreen-Based Assays: Ultra-High-Throughput Screening for Small-Molecule Inhibitors of Challenging Enzymes and Protein-Protein Interactions.
Yasgar A; Jadhav A; Simeonov A; Coussens NP
Methods Mol Biol; 2016; 1439():77-98. PubMed ID: 27316989
[TBL] [Abstract][Full Text] [Related]
33. Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology.
Takai A; Eto M; Hirano K; Takeya K; Wakimoto T; Watanabe M
J Physiol Sci; 2018 Jan; 68(1):1-17. PubMed ID: 28681362
[TBL] [Abstract][Full Text] [Related]
34. [High-throughput screening of human soluble epoxide hydrolase inhibitors].
Wang SB; Guo J; Yu XM; Du GH
Yao Xue Xue Bao; 2010 Nov; 45(11):1367-72. PubMed ID: 21361036
[TBL] [Abstract][Full Text] [Related]
35. Protein Phosphatase 1c Associated with the Cardiac Sodium Calcium Exchanger 1 Regulates Its Activity by Dephosphorylating Serine 68-phosphorylated Phospholemman.
Hafver TL; Hodne K; Wanichawan P; Aronsen JM; Dalhus B; Lunde PK; Lunde M; Martinsen M; Enger UH; Fuller W; Sjaastad I; Louch WE; Sejersted OM; Carlson CR
J Biol Chem; 2016 Feb; 291(9):4561-79. PubMed ID: 26668322
[TBL] [Abstract][Full Text] [Related]
36. Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors.
Johnston PA; Foster CA; Shun TY; Skoko JJ; Shinde S; Wipf P; Lazo JS
Assay Drug Dev Technol; 2007 Jun; 5(3):319-32. PubMed ID: 17638532
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a novel protein inhibitor of type 1 protein phosphatase.
Shirato H; Shima H; Sakashita G; Nakano T; Ito M; Lee EY; Kikuchi K
Biochemistry; 2000 Nov; 39(45):13848-55. PubMed ID: 11076525
[TBL] [Abstract][Full Text] [Related]
38. Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer.
Kim TG; Lee JH; Lee MY; Kim KU; Lee JH; Park CH; Lee BH; Oh KS
Biol Pharm Bull; 2017; 40(9):1454-1462. PubMed ID: 28867728
[TBL] [Abstract][Full Text] [Related]
39. Inhibitor-2 functions like a chaperone to fold three expressed isoforms of mammalian protein phosphatase-1 into a conformation with the specificity and regulatory properties of the native enzyme.
Alessi DR; Street AJ; Cohen P; Cohen PT
Eur J Biochem; 1993 May; 213(3):1055-66. PubMed ID: 8389292
[TBL] [Abstract][Full Text] [Related]
40. High-throughput screening for protein tyrosine phosphatase activity modulators.
Tautz L; Sergienko EA
Methods Mol Biol; 2013; 1053():223-40. PubMed ID: 23860657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
